Semaglutide Price, Compounding Rules, and What’s Legal Now
Semaglutide price and access look very different than they did a couple of years ago. The FDA-recognized shortage that once allowed broad compounding ended in 2025, and enforcement has increased since. This guide covers what changed, why it changed, and what can legitimately lower your cost today if you’re prescribed Ozempic or Wegovy.
If you looked into compounded semaglutide a couple of years ago, it’s worth a second look today. Chances are, that option isn’t open anymore.
The FDA-recognized shortage that made broad compounding legal ended in February 2025. The wind-down periods that followed have long since ended. That doesn’t mean your options disappeared. It simply means the path forward looks different now.
Explore Ozempic pricing across our network to see what’s actually available today. It’s a brand-name product sourced from a licensed pharmacy, not a compounded version chasing a shortage that no longer exists.
What a Compounding Pharmacy Is, and Why the Window Opened in the First Place
A compounding pharmacy prepares customized medications. Often, that’s for a specific patient requirement that a mass-produced drug can’t meet. Think of a different dose or an ingredient substitution for someone with an allergy.
Federal law allows a narrow exception to these rules. When the FDA formally lists a drug as being in shortage, compounding pharmacies can step in. They can prepare a version that’s “essentially a copy” of the FDA-approved product to help fill the gap.
Semaglutide is the active ingredient in Ozempic and Wegovy. It remained on the shortage list for several years as demand outpaced supply. That’s why compounded versions became so widely available and heavily advertised during that period.
What Changed? The Shortage Is Over, and So Is the Broad Exception
The FDA declared the semaglutide shortage resolved in February 2025. That triggered wind-down periods for compounders.
State-licensed pharmacies compounding under section 503A had until April 22, 2025. Larger outsourcing facilities compounding under section 503B had until May 22, 2025.
In April 2026, the FDA went further. It proposed excluding semaglutide, along with tirzepatide and liraglutide, from the list of substances outsourcing facilities can compound. The reasoning? No clinical need for the exception, regardless of shortage status.
The Safety Data Behind the Shift
This shift isn’t just a paperwork change. In July 2024, the FDA issued a public alert about adverse events tied to compounded semaglutide. Many involved dosing errors, from prescriptions calling for higher-than-recommended starting doses to faster-than-recommended dose increases.
The agency’s compliance office also reported issuing 314 warning letters in fiscal year 2025. That’s a sharp increase, driven partly by compounded drugs advertised with misleading claims. Some of those claims presented compounded semaglutide as equivalent to the FDA-approved product.
Novo Nordisk and Eli Lilly make the FDA-approved GLP-1 products. Both have pursued legal action against companies they say misrepresented compounded versions as the real thing.
What’s Still Legally Possible, and What Isn’t
Broad, shortage-based compounding of a copy of Ozempic or Wegovy is no longer permitted. A narrow exception remains, but it’s specific.
It applies only to a genuine patient-specific need, such as a different dose or a formulation change tied to a documented medical reason. Affordability on its own doesn’t qualify. The FDA has been explicit about this.
If you’re weighing this path, that’s a conversation for you and your prescriber. It’s not a decision to make on your own based on what a compounding pharmacy’s website says.
Semaglutide Price: What Brand-Name Access Actually Costs
Brand-name Wegovy carries a US list price around $1,349 a month. The same product, sourced through our Canadian-licensed network, runs closer to $563 for a pack. Ozempic follows a similar pattern. Our Canadian listings run around $357 per pen, well below typical US list pricing.
A 2026 manufacturer cash-price program has also brought Wegovy’s price down to around $199 a month for eligible uninsured, cash-paying patients. It’s worth checking directly, since eligibility and pricing on manufacturer programs can shift.
None of these routes involve compounding. They’re the same FDA-approved product, just priced differently by source.
What to Do if You’re Currently on a Compounded Version
If you’re currently taking a compounded semaglutide product, don’t stop it abruptly. Talk to your prescriber first. Have that conversation soon.
Ask specifically whether your situation fits the narrow patient-specific exception that’s still legal. If it doesn’t, ask what a transition to an FDA-approved brand-name product would look like, including the cost-saving options above.
The FDA-Approved Product, at a Price That Makes Sense
You shouldn’t have to choose between an FDA-approved GLP-1 medication and an affordable price. See what Ozempic and Wegovy actually cost across our licensed network before you decide on anything else.
Compounded Semaglutide Questions Worth Getting Straight Answers To
What Counts as a “Patient-Specific Need” Under the Remaining Exception?
Something concrete and documented, not a general preference. A genuine allergy to an inactive ingredient in the FDA-approved product is one example. Another example is a dose your prescriber has determined the commercial product can’t provide. Affordability alone doesn’t qualify, no matter how a compounding pharmacy’s marketing frames it.
Why Did the FDA Change Its Position on Compounded GLP-1 Drugs?
The shortage that justified the exception ended in February 2025. Since then, the FDA has pointed to adverse event reports tied to compounded versions. The FDA cited dosing errors and misleading marketing claims as reasons for closing the exception rather than extending it.
Is Ozempic or Wegovy Covered by Insurance?
Coverage varies significantly by plan. It also depends on whether the prescription is for diabetes management or weight management specifically, since many plans treat those differently. Check your specific formulary, and ask your prescriber’s office whether a prior authorization is required.
Can I Just Switch From a Compounded Version to Brand-Name on My Own?
Talk to your prescriber first. Dosing between compounded and brand-name products isn’t always a direct match. A supervised transition is safer than switching on your own.
Your Answer on Semaglutide Price and What’s Actually Legal
The compounding rules changed. Your options for affording the real thing didn’t disappear; they just look different now. See what an FDA-approved product actually costs through a licensed international pharmacy.
A quick note about your health: We are dedicated to providing you with safe, affordable access to your prescription medications. However, the information on this website is for educational purposes and should not replace professional medical advice. Always consult your physician or healthcare professional before taking any new prescription or over-the-counter medication. If you are experiencing a medical emergency, please call 911 immediately.